Mengchan Zhu
-
- MicroRNA in disease regulation 6
-
- Air Quality and Health Impacts 3
-
- Circular RNAs in diseases 6
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 5
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 3
-
- Asthma and respiratory diseases 5
-
- Eosinophilic Esophagitis 3
-
- IL-33, ST2, and ILC Pathways 3
- Journals
- Ecotoxicology and Environmental Safety (3 papers)International Journal of COPD (2 papers)Respiratory Research (2 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Mengchan Zhu
21 papers receiving 428 citations
Peers
Comparison fields: 5 of 80
- Cancer Research 156
- Health, Toxicology and Mutagenesis 58
- Molecular Biology 245
- Pulmonary and Respiratory Medicine 108
- Physiology 51
Countries citing papers authored by Mengchan Zhu
This map shows the geographic impact of Mengchan Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengchan Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengchan Zhu more than expected).
Fields of papers citing papers by Mengchan Zhu
This network shows the impact of papers produced by Mengchan Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengchan Zhu. The network helps show where Mengchan Zhu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mengchan Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 17 | |
| 5 | Clinical Characteristics and Prognosis of Allergic Bronchopulmonary Aspergillosis: A Retrospective Cohort Study | 2022 | 16 |
| 6 | 2022 | 30 | |
| 7 | 2022 | 6 | |
| 8 | 2022 | 16 | |
| 9 | 2022 | 11 | |
| 10 | 2021 | 13 | |
| 11 | 2021 | 14 | |
| 12 | 2021 | 0 | |
| 13 | 2020 | 15 | |
| 14 | 2020 | 37 | |
| 15 | 2020 | 11 | |
| 16 | 2020 | 11 | |
| 17 | 2020 | 14 | |
| 18 | 2019 | 18 | |
| 19 | 2019 | 70 | |
| 20 | 2018 | 50 |
About Mengchan Zhu
Mengchan Zhu is a scholar working on Cancer Research, Physiology and Health, Toxicology and Mutagenesis, having authored 23 papers that have together received 432 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (6 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), Asthma and respiratory diseases (5 papers), Air Quality and Health Impacts (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Eosinophilic Esophagitis (3 papers) and IL-33, ST2, and ILC Pathways (3 papers). The work is most often cited by research in Cancer Research (156 citations), Health, Toxicology and Mutagenesis (58 citations) and Molecular Biology (245 citations). Mengchan Zhu has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Cuicui Chen, Yuanlin Song, Jian Wang, Ling Ye, Shijin Xia, Jian Wang, Meiling Jin, Jue Pan, Hui Cai and Yuanlin Song. Their work appears in journals such as Ecotoxicology and Environmental Safety, International Journal of COPD, Respiratory Research, Oxidative Medicine and Cellular Longevity and Aging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.